The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results